VISCERAL LEISHMANIASIS IN HIV-INFECTED PATIENTS IN THE SOUTH OF FRANCE

被引：0

作者：

DEREURE, J ^{[1
]}

REYNES, J ^{[1
]}

PRATLONG, F ^{[1
]}

LAMAURY, I ^{[1
]}

RIOUX, JA ^{[1
]}

JANBON, F ^{[1
]}

DEDET, JP ^{[1
]}

机构：

[1] HOP GUI DE CHAULIAC,SERV MALAD INFECT & TROP,MONTPELLIER,FRANCE

来源：

BULLETIN OF THE WORLD HEALTH ORGANIZATION | 1995年 / 73卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Between 1989 and 1993, investigations by classical parasitological procedures of 139 HIV-infected adults living in visceral leishmaniasis (VL) endemic areas showed that 10 of them (7.2%) were positive for Leishmania (by stained smears and culture). In the same period we identified 15 VL cases in patients not infected with HIV. Thus, 40% (10/25) of our VL cases were associated with HIV infection.

引用

页码：245 / 246

页数：2

共 50 条

[31] Comment on: Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients
Collazos, Julio
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (02) : 466 - 467
[32] Ultrasensitive Real-Time PCR for the Clinical Management of Visceral Leishmaniasis in HIV-Infected Patients
Molina, Israel
Fisa, Roser
Riera, Cristina
Falco, Vicenc
Elizalde, Aleix
Salvador, Fernando
Crespo, Manuel
Curran, Adrian
Lopez-Chejade, Paulo
Tebar, Silvia
Perez-Hoyos, Santiago
Ribera, Esteban
Pahissa, Albert
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2013, 89 (01): : 105 - 110
[33] VISCERAL LEISHMANIASIS IN AN HIV-INFECTED PATIENT - CLINICAL-FEATURES AND RESPONSE TO TREATMENT
FENSKE, S
STELLBRINK, HJ
ALBRECHT, H
GRETEN, H
KLINISCHE WOCHENSCHRIFT, 1991, 69 (17): : 793 - 796
[34] Disseminated Penicillium marneffei infection suggesting visceral leishmaniasis in an HIV-infected patient
Rosenthal, E
Marty, P
Ferrero, C
Le Fichoux, Y
Cassuto, JP
PRESSE MEDICALE, 2000, 29 (07): : 363 - 364
[35] VISCERAL LEISHMANIASIS IN PATIENTS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV)
BERENGUER, J
MORENO, S
CERCENADO, E
DEQUIROS, JCLB
DELAFUENTE, AG
BOUZA, E
ANNALS OF INTERNAL MEDICINE, 1989, 111 (02) : 129 - 132
[36] Exploring prognosis in chronic relapsing visceral leishmaniasis among HIV-infected patients: Circulating Leishmania DNA
Cota, Glaucia Fernandes
de Sousa, Marcos Roberto
Machado de Assis, Talia Santana
Pinto, Bruna Fernandes
Rabello, Ana
ACTA TROPICA, 2017, 172 : 186 - 191
[37] Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients
López-Vélez, R
Videla, S
Márquez, M
Boix, V
Jiménez-Mejías, ME
Górgolas, M
Arribas, JR
Salas, A
Laguna, F
Sust, M
Cañavate, C
Alvar, J
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (03) : 540 - 543
[38] INDIRECT XENODIAGNOSIS OF VISCERAL LEISHMANIASIS IN 10 HIV-INFECTED PATIENTS USING COLONIZED PHLEBOTOMUS-PERNICIOSUS
MOLINA, R
CANAVATE, C
CERCENADO, E
LAGUNA, F
LOPEZVELEZ, R
ALVAR, J
AIDS, 1994, 8 (02) : 277 - 279
[39] Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients
Tortajada, C
Pérez-Cuevas, B
Moreno, A
Martínez, E
Mallolas, J
García, F
Valls, E
Miró, JM
De Lazzari, E
Gatell, JM
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 30 (03) : 364 - 366
[40] Treatment of visceral leishmaniasis in HIV-infected patients:: a randomized trial comparing meglumine antimoniate with amphotericin B
Laguna, F
López-Vélez, R
Pulido, F
Salas, A
Torre-Cisneros, J
Torres, E
Medrano, FJ
Sanz, J
Picó, G
Gómez-Rodrigo, J
Pasquau, J
Alvar, J
AIDS, 1999, 13 (09) : 1063 - 1069

← 1 2 3 4 5 →